BiotechTube
Home/PEP-Therapy/Antoine Prestat
AP

Antoine Prestat

Co-founder and CEO

PEP-Therapy

Therapeutic Areas

Oncology

PEP-Therapy Pipeline

DrugIndicationPhase
PEP-010Recurrent and/or metastatic solid tumors (including pancreatic cancer)Phase 1a/b

Leadership Team at PEP-Therapy

JS
Jennifer Sengenès, PhD
Head of Strategy and Development
HA
Hatem Azim, MD, PhD
Chief Medical Officer
LD
Laura Dadon, PharmD
Head of Drug Development
DG
Diego Germini, PhD
Head of Research
View full PEP-Therapy profile